Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09GEK
|
||||
Former ID |
DNCL002360
|
||||
Drug Name |
ASP3026
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Astellas Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C29H40N8O3S
|
||||
InChI |
InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34)
|
||||
InChIKey |
MGGBYMDAPCCKCT-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | ALK tyrosine kinase receptor | Target Info | Modulator | [542706] | |
KEGG Pathway | Non-small cell lung cancer | ||||
WikiPathways | Differentiation Pathway | ||||
References | |||||
Ref 523558 | ClinicalTrials.gov (NCT01401504) Study of an Investigational Drug, ASP3026, in Patients With Solid Tumors. U.S. National Institutes of Health. | ||||
Ref 542706 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7740). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.